LaPlume Joseph W (CIK 1767215) reported 19 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-08-11). Recent activity: Sell CRL (257 shares), Buy CRL (5,257 shares), Sell CRL (744 shares), Sell CRL (235 shares), Sell CRL (243 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-11 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | EVP, Corp Strategy & Develop | Sell | 257 | $0 |
| 2026-06-02 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | EVP, Corp Strategy & Develop | Buy | 5,257 | $949,992 |
| 2026-06-02 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | EVP, Corp Strategy & Develop | Sell | 744 | $134,448 |
| 2026-06-02 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | EVP, Corp Strategy & Develop | Sell | 235 | $42,467 |
| 2026-05-28 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | EVP, Corp Strategy & Develop | Sell | 243 | $38,953 |
| 2026-05-28 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | EVP, Corp Strategy & Develop | Sell | 185 | $28,995 |
| 2026-03-04 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | EVP, Corp Strategy & Develop | Buy | 25 | $4,364 |
| 2026-02-03 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | EVP, Corp Strategy & Develop | Buy | 5,456 | $0 |
| 2026-02-03 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | EVP, Corp Strategy & Develop | Sell | 1,749 | $370,228 |
| 2026-01-20 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | EVP, Corp Strategy & Develop | Sell | 400 | $65,488 |
| 2025-08-20 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | EVP, Corp Strategy & Develop | Sell | 800 | $126,080 |
| 2025-08-08 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | EVP, Corp Strategy & Develop | Sell | 400 | $60,016 |
| 2025-06-09 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | EVP, Corp Strategy & Develop | Sell | 385 | $0 |
| 2025-06-03 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | EVP, Corp Strategy & Develop | Buy | 6,709 | $909,942 |
| 2025-06-03 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | EVP, Corp Strategy & Develop | Sell | 155 | $21,023 |
| 2025-05-29 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | EVP, Corp Strategy & Develop | Sell | 161 | $22,014 |
| 2025-05-29 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | EVP, Corp Strategy & Develop | Sell | 122 | $16,681 |
| 2025-05-29 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | EVP, Corp Strategy & Develop | Sell | 83 | $11,508 |
| 2025-05-15 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | EVP, Corp Strategy & Develop | Sell | 500 | $72,705 |
Source: SEC Form 4 filings · as of 2026-08-11